Josef Mautner

Title: Inventor Josef Mautner: A Pioneer in Immunology

Introduction

Josef Mautner, a distinguished inventor based in Munich, Germany, has made significant contributions to the field of immunology through his innovative research. With a total of two patents to his name, Mautner has successfully developed methods that enhance our understanding and treatment of immune responses, particularly concerning CD4+ T cells.

Latest Patents

Mautner's latest patents reflect his focus on advancing medical science. The first patent, titled "Method of identifying CD4+ T cell antigens," is directed towards a technique for identifying CD4+ T cell antigens along with the associated antigens identified through this process. This invention holds potential applications in medicine, offering new avenues for treatment and diagnosis.

His second patent, "Ex vivo method for producing a preparation containing CD4+ T cells specific for EBV structural antigens," introduces a method for producing CD4+ T cell preparations targeting EBV structural antigens. This method aims to support the prophylaxis and treatment of patients with diminished T cell activity, ultimately helping to manage EBV-infected B cell growth effectively.

Career Highlights

Throughout his career, Josef Mautner has collaborated with notable research institutions, including the Helmholtz Zentrum München – Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) and the Deutsches Krebsforschungszentrum (DKFZ). His work in these organizations underscores his commitment to advancing research in health and disease treatment.

Collaborations

Mautner has worked alongside esteemed colleagues such as Uta Behrends and Dinesh Adhikary, contributing to multidisciplinary approaches in research. These collaborations have enriched his projects and allowed him to leverage diverse expertise in the scientific community.

Conclusion

Josef Mautner's innovative work in the field of immunology exemplifies the spirit of invention and progress. With his patented methods for identifying and utilizing CD4+ T cell antigens, he continues to play a pivotal role in advancing medical science, impacting the lives of many individuals affected by immune disorders. His contributions further solidify the importance of collaborative research in developing effective medical solutions.